These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32151462)

  • 41. Prevalence and risk factors for HBV and HCV in prisoners in Iran: a national bio-behavioural surveillance survey in 2015.
    Moradi G; Gouya MM; Azimizan Zavareh F; Mohamadi Bolbanabad A; Darvishi S; Aghasadeghi MR; Nabavi M; Alasvand R; Tashakorian M; Nouri B; Rahmani K; Molaei L
    Trop Med Int Health; 2018 Jun; 23(6):641-649. PubMed ID: 29698576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High prevalence of human immunodeficiency virus, hepatitis B and C viral infections among people who inject drugs: a potential stumbling block in the control of HIV and viral hepatitis in Tanzania.
    Kawambwa RH; Majigo MV; Mohamed AA; Matee MI
    BMC Public Health; 2020 Feb; 20(1):177. PubMed ID: 32019536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Associations between the prevalence of chronic hepatitis B among people who inject drugs and country-level characteristics: An ecological analysis.
    Syangbo A; Hickman M; Colledge-Frisby S; Leung J; Grebely J; Larney S; Degenhardt L; Trickey A
    Drug Alcohol Rev; 2023 Mar; 42(3):569-581. PubMed ID: 36600489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serological markers and risk factors associated with Hepatitis B virus infection among Federal Capital Territory prison inmates, Nigeria: Should we be concerned?
    Dan-Nwafor CC; Adeoye I; Aderemi K; Onuoha M; Adedire E; Bashorun A; Osunkwo D; Gidado S; Balogun M; Idris S; Ade-Yusuf I; Udom E; Nguku P
    PLoS One; 2021; 16(3):e0248045. PubMed ID: 33705419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Burden of HIV, Syphilis, and Hepatitis B and C Among Inmates in a Prison State System in Mexico.
    Belaunzaran-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Rodríguez-Ramírez S; Sierra-Madero J; Beyrer C
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):524-533. PubMed ID: 28094553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Seroprevalence of markers for hepatitis B, C and G in male and female prisoners--NSW, 1996.
    Butler T; Spencer J; Cui J; Vickery K; Zou J; Kaldor J
    Aust N Z J Public Health; 1999 Aug; 23(4):377-84. PubMed ID: 10462860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis B and human immunodeficiency virus infections within correctional facilities in Ghana.
    Sagoe KWC; Atuahene K; Ayiku ANA; Pappoe-Ashong PJ; Boamah I; Till H; Hagbe FS; Egyire IK; Nyampong M; Addo SA; Manu A; Noora CL; Tetteh M; Ankomah A; Adanu R
    PLoS One; 2023; 18(11):e0293009. PubMed ID: 37922278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis B and Hepatitis C in prisons: a prevalence study.
    Kose S; Adar P; Gozaydin A; Kuzucu L; Akkoclu G
    Int J Prison Health; 2019 Jun; 15(2):162-167. PubMed ID: 31172859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seroprevalence of hepatitis B virus infection and associated factors among prison inmates in state of Mato Grosso do Sul, Brazil.
    Stief AC; Martins RM; Andrade SM; Pompilio MA; Fernandes SM; Murat PG; Mousquer GJ; Teles SA; Camolez GR; Francisco RB; Motta-Castro AR
    Rev Soc Bras Med Trop; 2010; 43(5):512-5. PubMed ID: 21085860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Viral hepatitis B, C and HIV infection in Croatian prisons.
    Burek V; Horvat J; Butorac K; Mikulić R
    Epidemiol Infect; 2010 Nov; 138(11):1610-20. PubMed ID: 20202285
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiology of the viral hepatitis B and C in female prisoners of Metropolitan Regional Prison Complex in the State of Goiás, Central Brazil.
    Barros LA; Pessoni GC; Teles SA; Souza SM; Matos MA; Martins RM; Del-Rios NH; Matos MA; Carneiro MA
    Rev Soc Bras Med Trop; 2013; 46(1):24-9. PubMed ID: 23563821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.
    Prasetyo AA; Dirgahayu P; Sari Y; Hudiyono H; Kageyama S
    J Infect Dev Ctries; 2013 Jun; 7(6):453-67. PubMed ID: 23771289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Injecting drug use is an independent risk factor for reincarceration after release from prison: A prospective cohort study.
    Winter RJ; Stoové M; Agius PA; Hellard ME; Kinner SA
    Drug Alcohol Rev; 2019 Mar; 38(3):254-263. PubMed ID: 30569550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
    Dolan K; Wirtz AL; Moazen B; Ndeffo-Mbah M; Galvani A; Kinner SA; Courtney R; McKee M; Amon JJ; Maher L; Hellard M; Beyrer C; Altice FL
    Lancet; 2016 Sep; 388(10049):1089-1102. PubMed ID: 27427453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV infection, viral hepatitis and liver fibrosis among prison inmates in West Africa.
    Jaquet A; Wandeler G; Tine J; Dagnra CA; Attia A; Patassi A; Ndiaye A; de Ledinghen V; Ekouevi DK; Seydi M; Dabis F
    BMC Infect Dis; 2016 Jun; 16():249. PubMed ID: 27267370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Consensus recommendations on the management of hepatitis C in Australia's prisons.
    Winter RJ; Sheehan Y; Papaluca T; Macdonald GA; Rowland J; Colman A; Stoove M; Lloyd AR; Thompson AJ
    Med J Aust; 2023 Mar; 218(5):231-237. PubMed ID: 36871200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HBV and HCV serological monitoring among injection drugs users in opiate substitution treatment in Bosnia and Herzegovina.
    Skocibusic S; Martinac M; Arapovic J; Grgic S; Nikolic J; Hasanagic D; Bevanda M; Ravlija J
    J Infect Dev Ctries; 2016 Sep; 10(9):968-972. PubMed ID: 27694729
    [TBL] [Abstract][Full Text] [Related]  

  • 59. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
    Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I
    Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening for hepatitis B virus and accelerated vaccination schedule in prison: A pilot multicenter study.
    Stasi C; Monnini M; Cellesi V; Salvadori M; Marri D; Ameglio M; Gabbuti A; Di Fiandra T; Voller F; Silvestri C
    Vaccine; 2019 Mar; 37(11):1412-1417. PubMed ID: 30733091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.